Coswald Consulting began in 2015 as consulting firm offering assistance in pharmaceutical development, including services necessary to develop biopharmaceutical therapeutics, with a strong underlying specialty in oligonucleotide therapeutics.
Chris Oswald, Principal Consultant
Chris Oswald has more than 20 years of GMP pharmaceutical experience. Having a background as a manufacturing manager in the pharmaceutical contract manufacturing (CMO) industry, he has experienced the realities of balancing revenue delivery with quality, while navigating the challenges of shepherding products through the molecular development process.
Chris has directly managed active pharmaceutical ingredient (API)/drug substance manufacturing and quality operations for one of the largest oligonucleotide contract manufacturing sites in North America. He has been responsible for developing multiple products from pre-clinical through process validation and pre-commercial stages. In addition, he has also presided over quality control operations for a large generic tablet site.
Chris has taken on projects and activities ranging from facility design/build to process modeling and optimization, from quality system engineering to authoring production reports, from sourcing equipment to drafting regulatory documentation, from acting as a corporate quality representative to performing person-in-plant services, from technical document writing and review to performing process characterization, and from establishing cleaning programs to site and system auditing.